Keflex (Cephalexin) Dosing in Renal Failure
In patients with renal impairment, cephalexin requires dose adjustment by prolonging the dosing interval rather than reducing individual doses, with careful monitoring essential due to the drug's predominant renal elimination.
Renal Dose Adjustment Strategy
Standard Approach
- Cephalexin should be administered with caution in markedly impaired renal function, with careful clinical observation and laboratory monitoring 1
- The primary adjustment method involves prolonging the dosing interval rather than reducing the dose per administration 2
- For patients on dialysis, the recommended adjustment is prolongation of the dosing interval to every 24 hours 2
Specific Dosing Recommendations Based on Creatinine Clearance
For patients with varying degrees of renal impairment:
- The elimination rate constant (Ke) correlates directly with creatinine clearance: Ke = 0.0766 + 0.0060 × CrCl 3
- In patients with CrCl = 0 mL/min (anephric), the serum half-life extends to approximately 8.47 hours (compared to ~1 hour in normal function) 3
- The half-life increases from 40 minutes at CrCl 100 mL/min to 15.4 hours in anephric patients 4
Critical Consideration: Tubular Secretion
A major pitfall in cephalexin dosing is relying solely on creatinine clearance for dose adjustment:
- Cephalexin depends heavily on active renal tubular secretion for elimination, not just glomerular filtration 5, 6
- In renal failure, there is substantial diminution of maximum tubular secretion capacity that exceeds the reduction in glomerular filtration 6
- Studies demonstrate that dosage intervals may need to be prolonged up to 20 times normal when considering both glomerular and tubular dysfunction, whereas creatinine clearance alone would suggest only 5 times prolongation 6
- A combined assessment using both creatinine clearance and tubular function (PSP15' test) provides superior dosing control compared to creatinine clearance alone 5
Practical Dosing Algorithm
Loading Dose
- Administer a full loading dose based on patient weight, as the loading dose is not affected by renal function 3
- Standard loading dose: 500 mg orally 3, 4
Maintenance Dosing
For patients on hemodialysis:
- 250-500 mg every 24 hours (prolonged from every 6-8 hours) 2
- Administer dose after dialysis to avoid premature drug removal 7
For patients with moderate renal impairment (CrCl 15-50 mL/min):
- 500 mg every 12-24 hours depending on severity 4
- Use the nomogram approach: calculate appropriate interval based on corrected creatinine clearance 4
For patients with severe renal impairment (CrCl <15 mL/min):
- 500 mg every 24 hours or longer 3, 4
- Consider that intervals may need extension beyond what creatinine clearance alone suggests due to tubular dysfunction 6
Monitoring Requirements
- Careful clinical observation is essential as safe dosage may be lower than usually recommended 1
- Monitor for drug accumulation and toxicity, particularly with repeated dosing 1
- In dialysis patients, serum drug concentrations should be monitored when possible to avoid toxicity 7
- Assess for therapeutic efficacy and adverse effects throughout treatment 8
Drug Interactions in Renal Failure
- Probenecid inhibits renal excretion of cephalexin, further prolonging half-life 1
- Metformin coadministration requires careful monitoring, as cephalexin can increase metformin exposure by inhibiting tubular secretion 1